Baloxavir Marboxil

Item number	Size	Manual	SDS	Delivery time	Price
LKT-B011460.5	5 mg	-	-	3 - 8 business days*	62.00€
LKT-B011460.25	25 mg	-	-	3 - 8 business days*	104.00€
LKT-B011460.100	100 mg	-	-	3 - 8 business days*	173.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Baloxavir, and its prodrug baloxavir marboxil, is a cap-dependent endonuclease inhibitor, leading... more

Close menu

Product information "Baloxavir Marboxil"

Baloxavir, and its prodrug baloxavir marboxil, is a cap-dependent endonuclease inhibitor, leading to inhibition of RNA transcription and replication. Baloxavir shows potent activity against two influenza A strains with noted synergistic effects when used in combination with oseltamivir. Baloxavir has also been investigated for its potential to treat COVID-19 but no proven benefit has been observed. Solubility: DMSO.

Keywords:	Xofluza, S-033188, [(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-9,12-dioxo-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-yl]oxymethyl methyl carbonate
Supplier:	LKT Laboratories
Supplier-Nr:	B011460